Method for testing genetic toxicity TK gene mutation of novel tobacco aerosol aqueous extract
By using FM cell culture medium and mouse lymphoma cells in vitro to detect the resistance mutation frequency of novel tobacco aerosol extracts, combined with the metabolic activation system S9, the problem of lack of in vitro genotoxicity testing methods in the field of e-cigarette smoke is solved. Accurate evaluation of the mutagenic effect of the new tobacco aerosol extract was achieved.
CN119082252APending Publication Date: 2024-12-06SHENZHEN HANGSEN STAR TECH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CN202411493368.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-24
- Publication Date
- 2024-12-06
Smart Images

Figure BDA0005100650090000041 
Figure BDA0005100650090000042 
Figure BDA0005100650090000043
Abstract
The invention relates to a TK gene mutation test method for evaluating genetic toxicity of a novel tobacco aerosol aqueous extract, and belongs to the technical field of novel tobacco hazard evaluation. According to the genetic toxicity testing method disclosed by the invention, the tested cells are directly treated by adopting the novel tobacco aerosol aqueous extract, so that the mutagenic effect of the novel tobacco aerosol aqueous extract can be qualitatively judged. The method makes up the blank of novel tobacco in-vitro cell genetic toxicity evaluation, can be suitable for different types of novel tobaccos in the market, such as electronic cigarettes and simulated cigarettes, can realize transverse comparison between different novel tobacco TK gene mutagenesis effects, and can also be used for evaluating the harm reduction effect between the novel tobaccos and the cigarettes through the method.
Need to check novelty before this filing date? Find Prior Art
